Patient info Open main menu

Celluvisc 0.5% w/v eye drop solution unit dose – patient leaflet, side effects, dosage

Text from the MHRA, as of · About this document

Medicine status: Pharmacy medicine (P) Details

Medicine strength:
0.5% w/v (5 mg/ml)
Contains active substance:

Patient leaflet - Celluvisc 0.5% w/v eye drop solution unit dose

1. What CELLUVISC is and what it is

CELLUVISC® is a substitute for tears, and sodium. It is used for the treatment of the s irritation or dryness) caused by you not pro

2. What you need to know before you

Do not use CELLUVISC®

  • If you are hypersensitive (allergic) to ca

    of this medicine (listed in section 6). Warnings and precautions

  • If irritation, pain, redness or changes in

    getting worse, stop taking this medicin Other medicines and CELLUVISC®

Please tell your doctor or pharmacist if you other medicines, including medicines obta

used for

contains the lubricant called carmellose ymptoms of dry eye (such as soreness, burning, ducing enough tears to keep the eye wet.

use CELLUVISC®

rmellose sodium or any of the other ingredients

vision occur or if you feel your condition is e and consult your doctor or pharmacist.

are using, have recently used or might use any ined without a prescription.

If you are using other eye drops, leave at le drops and CELLUVISC®.

Pregnancy and breast-feeding

You can use CELLUVISC® if you are pregn Driving and using machines

CELLUVISC® may cause temporary blurri blurring, do not drive or use machines until Read all the information in this leaflet befor If you are unsure about anything, discuss it

3. How to use CELLUVISC®

Always use this medicine exactly as descri or nurse has told you. Check with your doc The recommended dose is 1-2 drops of C eye, 4 times a day or as often as needed.

ast 15 minutes between putting in the other

ant and when you are breast-feeding.

ng of vision. If you do experience temporary your sight is clear.

e using CELLUVISC®.

with your doctor, nurse or pharmacist.

bed in this leaflet or as your doctor, pharmacist tor, pharmacist or nurse if you are not sure. ELLUVISC® in the affected eye/each affected

You do not need to remove contact lenses Make sure that the single-dose container i immediately after opening.To avoid conta open-end of the single-dose container tou before use.

  1. 1. 2.
  2. 1. Tear one single-dose container
  3. 2.

    Hold the single-dose container

    twist off the top.

    before using CELLUVISC®.

    s intact before use. The solution should be used mination or possible eye injury, do not let the ch your eye or anything else.Wash your hands

    3.

    from the strip.

    upright (with the top uppermost) and

  4. 3.

    Gently pull down the lower eyel

    dose container upside down an each eye. Blink your eyes a few Do not re-use the single-dose container ev most important that you throw it away and If you use more CELLUVISC® than you

It will not cause you any harm. If you are wo

id to form a pocket. Turn the single-d squeeze it to release one drop into times.

en if there is some solution left. It is do not keep it.

should

rried, talk to your doctor or pharmacist.

If you forget to use CELLUVISC®

Use a single drop in each eye that needs trea and then go back to your regular routine. Do n make up for forgetting to put drops in your eye If you have any further questions on the use o pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause s gets them.

The side effects are classified into the followi they occur:

Very common may affect more than 1 in

tment as soon as you remember, ot use a large number of drops to or eyes earlier.

f this medicine, ask your doctor, ide effects, although not everybody ng categories, depending on how often

10 people

Common

may affect up to 1 in 10 p

eople

Uncommon

may affect up to 1 in 100

people

Rare

may affect up to 1 in 1,00

0 people

Very rare

may affect up to 1 in 10,0

00 people

Not known

frequency cannot be esti

mated from the available data

The following side effects may be seen with C

ELLUVISC®:

Common

Eye irritation (including b visual disturbance.

urning and discomfort), eye pain, itchy eyes,

Not known

Allergic reactions (includi watery eye, redness of th due to the tip of the vial to

ng eye allergy), blurred vision, sticky eye, e eye, eye injury to the surface of the eye uching the eye during use.

Reporting of side effects

If you get any side effects, talk to your doctor side effects not listed in this leaflet.You can al Card Scheme, Website:www.mhra.gov.uk/ye the Google Play or Apple App Store. By reporting side effects you can help provide medicine.

5. How to store CELLUVISC®

Keep this medicine out of the sight and reach Do not store above 25°C.

Do not use this medicine after the expiry date single-dose container tab and the carton afte of that month.

Do not use if CELLUVISC® packaging shows e changes colour or becomes cloudy. Used CEL disposed of as household waste. Any unused

or pharmacist. This includes any possible so report side effects directly via the Yellow llowcard or search for MHRA Yellow Card in more information on the safety of this of children.

(use by date) which is stated on the r EXP:.The expiry date refers to the last day vidence of tampering. Do not use if solution LUVISC® eye drop containers can be containers can be returned to the pharmacist or he can tell you how to dispose of them safel

6. Contents of the pack and other inform

What CELLUVISC® contains

  • The active ingredient is carmellose sodiu
  • The other ingredients are sodium chloride calcium chloride dihydrate, magnesium ch amounts of sodium hydroxide or hydrochl to the correct pH (a measure of the acidity The ingredients and the amount used in CEL appears in tears produced naturally by the ey What CELLUVISC® looks like and content

CELLUVISC® is a clear, colourless to pale yell (bubble-like) casing (known as a ‘single-dose a twist-off top. Each single-dose container con

y (in order to protect the environment).

ation m 5 mg/ml.

, sodium lactate, potassium chloride, loride hexahydrate and purified water. Small oric acid may be added to bring the solution or alkalinity of the solution).

LUVISC® were chosen to match what e.

s of the pack ow eye drops solution in a small see-through container’). The single-dose container has tains 0.4 ml of eye drops solution.

Each pack contains 5, 30 or 90 single-dose co Marketing Authorisation Holder

AbbVie Ltd.

Maidenhead

SL6 4UB

UK

Manufacturer

Allergan Pharmaceuticals Ireland Castlebar Road

Westport

County Mayo

Ireland

This leaflet was last revised in 06/

ntainers. Not all pack sizes may be marketed.

2024.

20084732

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 41042/0060

MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Celluvisc 0.5% w/v eye drop solution unit dose

Prescription needed? No, but it is sold only in pharmacies (P)
Active substance Carmellose
Strength 0.5% w/v (5 mg/ml)
Pharmaceutical form Eye drops
How is it taken Ocular
Excipients Sodium chloride, Sodium lactate, Potassium chloride, Calcium chloride dihydrate, Magnesium chloride hexahydrate, Sodium hydroxide or hydrochloric acid (for pH adjustment) Purified water
Pack sizes 30 unit dose, 90 unit dose
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 18 months.
After first opening: Use immediately.
Storage Do not store above 25°C.
Drug group (ATC) Other ophthalmologicals
  1. S Sensory organ drugs
    1. S01 Ophthalmologicals
      1. S01X Other ophthalmologicals
        1. S01XA Other ophthalmologicals
          1. S01XA20 artificial tears and other indifferent preparations
Marketing authorisation PL 41042/0060 (first authorised 21 May 2010)
Marketing authorisation holder AbbVie Ltd.
Codes GTIN 4024787430535, 4024787430542 · BNF 11080100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.